Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL353002 | 0.88 | ALDH1A1 (0.48) | ALDH1A1THRBTSHRMGAMGAA | |
| SCHEMBL9350161 | 0.85 | ALDH1A1 (0.42) | ALDH1A1THRBTSHRMGAMGAA | |
| SCHEMBL4087701 | 0.82 | ALDH1A1 (0.47) | ALDH1A1THRBTSHRMGAMGAA | |
| SCHEMBL824134 | 0.80 | ALDH1A1 (0.41) | ALDH1A1THRBTSHRTET2EGLN1 | |
| SCHEMBL353003 | 0.80 | ALDH1A1 (0.41) | ALDH1A1HSD17B10TET2EGLN1 | |
| SCHEMBL28007316 | 0.79 | CES2 (0.46) | ALDH1A1TSHRHPGDHSD17B10MAPT | |
| SCHEMBL3689082 | 0.78 | ALDH1A1 (0.39) | ALDH1A1THRBTSHRMEN1KMT2A | |
| SCHEMBL21624609 | 0.78 | THRB (0.47) | ALDH1A1THRBTSHRHPGDMGAM | |
| SCHEMBL352782 | 0.78 | — | — | |
| SCHEMBL350033 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPTPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415751-B1 | ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | NIPPON CATALYTIC CHEM IND (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8796492-B2 | α-(unsaturated alkoxyalkyl) acrylate composition and process for production thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20130072712-A1 | ALPHA-SUBSTITUTED ACRYLATE ESTERS, COMPOSITION CONTAINING THEREOF, AND METHOD FOR PRODUCING THOSE | NIPPON SHOKUBAI CO, LTD (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2415751-A1 | ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | Nippon Shokubai Co., Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120016095-A1 | a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-19 | — | — | US | disclosed |
| CN-1828425-A | Pattern formation method | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2006-09-06 | — | — | CN | disclosed |
| CN-1523449-A | Pattern forming method | ���µ�����ҵ��ʽ���� | 2004-08-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072712-A1 | ALPHA-SUBSTITUTED ACRYLATE ESTERS, COMPOSITION CONTAINING THEREOF, AND METHOD FOR PRODUCING THOSE | ACR, ASPH, ADH1A | ALDH1A1 9/4885THRB 402/4885TSHR 2165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.